- Home
- RRR vs IRTC Comparison
RRR vs IRTC Comparison
Compare RRR & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RRR | IRTC |
|---|---|---|
| Founded | 1976 | 2006 |
| Country | United States | United States |
| Employees | N/A | 2400 |
| Industry | Hotels/Resorts | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | 2015 | 2016 |
Fundamental Metrics
Financial Performance| Metric | RRR | IRTC |
|---|---|---|
| Price | $56.03 | $114.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 13 |
| Target Price | $68.57 | ★ $200.23 |
| AVG Volume (30 Days) | ★ 850.2K | 461.7K |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.62% | N/A |
| EPS Growth | 23.32 | ★ 61.71 |
| EPS | ★ 3.12 | N/A |
| Revenue | ★ $2,011,483,000.00 | $747,138,000.00 |
| Revenue This Year | $3.46 | $19.60 |
| Revenue Next Year | $4.61 | $15.94 |
| P/E Ratio | $18.06 | ★ N/A |
| Revenue Growth | 3.74 | ★ 26.24 |
| 52 Week Low | $39.45 | $97.16 |
| 52 Week High | $68.99 | $210.01 |
Technical Indicators
Market Signals| Indicator | RRR | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 45.52 | 38.37 |
| Support Level | $55.56 | $112.65 |
| Resistance Level | $61.44 | $124.40 |
| Average True Range (ATR) | 2.02 | 4.67 |
| MACD | 0.26 | 1.06 |
| Stochastic Oscillator | 49.33 | 16.60 |
Price Performance
Historical ComparisonAbout RRR Red Rock Resorts Inc.
Red Rock Resorts Inc along with its subsidiary is a gaming, development and management company that develops and operates strategically-located casino and entertainment properties. Its casino properties are conveniently located throughout the Las Vegas valley and provide its customers a wide variety of entertainment and dining options. The majority of revenue is derived from Casinos.
About IRTC iRhythm Technologies Inc.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.